Follow the latest coverage, related explainers and connected technology stories.
Abbott has received the European CE mark for the Amulet 360, an upgraded version of its device for closing the left atrial appendage in certain patients with atrial fibrillation in order to reduce the risk of stroke. The company is preparing to expand the device’s use in European countries in the coming weeks, amid direct competition with Boston Scientific’s Watchman device.